Coupling_NN
of_IN
a_DT
signal_NN
response_NN
domain_NN
in_IN
I_NN
kappa_NN
B_NN
alpha_NN
to_TO
multiple_JJ
pathways_NNS
for_IN
NF-kappa_NN
B_NN
activation_NN
._.

The_DT
eukaryotic_JJ
transcription_NN
factor_NN
NF-kappa_NN
B_NN
plays_VBZ
a_DT
central_JJ
role_NN
in_IN
the_DT
induced_VBN
expression_NN
of_IN
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
and_CC
in_IN
many_JJ
aspects_NNS
of_IN
the_DT
genetic_JJ
program_NN
mediating_VBG
normal_JJ
T-cell_NN
activation_NN
and_CC
growth_NN
._.

The_DT
nuclear_JJ
activity_NN
of_IN
NF-kappa_NN
B_NN
is_VBZ
tightly_RB
regulated_VBN
from_IN
the_DT
cytoplasmic_JJ
compartment_NN
by_IN
an_DT
inhibitory_JJ
subunit_NN
called_NN
I_CD
kappa_NN
B_NN
alpha_NN
._.

This_DT
cytoplasmic_JJ
inhibitor_NN
is_VBZ
rapidly_RB
phosphorylated_VBN
and_CC
degraded_VBN
in_IN
response_NN
to_TO
a_DT
diverse_JJ
set_NN
of_IN
NF-kappa_NN
B-inducing_JJ
agents_NNS
,_,
including_VBG
T-cell_NN
mitogens_NNS
,_,
proinflammatory_JJ
cytokines_NNS
,_,
and_CC
viral_JJ
transactivators_NNS
such_JJ
as_IN
the_DT
Tax_NN
protein_NN
of_IN
human_JJ
T-cell_NN
leukemia_NN
virus_NN
type_NN
1_CD
._.

To_TO
explore_VB
these_DT
I_CD
kappa_NN
B_NN
alpha-dependent_JJ
mechanisms_NNS
for_IN
NF-kappa_NN
B_NN
induction_NN
,_,
we_PRP
identified_VBD
novel_JJ
mutants_NNS
of_IN
I_NN
kappa_NN
B_NN
alpha_NN
that_WDT
uncouple_VBP
its_PRP$
inhibitory_JJ
and_CC
signal-transducing_JJ
functions_NNS
in_IN
human_JJ
T_NN
lymphocytes_NNS
._.

Specifically_RB
,_,
removal_NN
of_IN
the_DT
N-terminal_JJ
36_CD
amino_NN
acids_NNS
of_IN
I_NN
kappa_NN
B_NN
alpha_NN
failed_VBD
to_TO
disrupt_VB
its_PRP$
ability_NN
to_TO
form_VB
latent_JJ
complexes_NNS
with_IN
NF-kappa_NN
B_NN
in_IN
the_DT
cytoplasm_NN
._.

However_RB
,_,
this_DT
deletion_NN
mutation_NN
prevented_VBD
the_DT
induced_JJ
phosphorylation_NN
,_,
degradative_JJ
loss_NN
,_,
and_CC
functional_JJ
release_NN
of_IN
I_NN
kappa_NN
B_NN
alpha_NN
from_IN
NF-kappa_NN
B_NN
in_IN
Tax-expressing_JJ
cells_NNS
._.

Alanine_NN
substitutions_NNS
introduced_VBN
at_IN
two_CD
serine_NN
residues_NNS
positioned_JJ
within_IN
this_DT
N-terminal_JJ
regulatory_JJ
region_NN
of_IN
I_NN
kappa_NN
B_NN
alpha_NN
also_RB
yielded_VBD
constitutive_JJ
repressors_NNS
that_WDT
escaped_VBD
from_IN
Tax-induced_JJ
turnover_NN
and_CC
that_IN
potently_RB
inhibited_VBD
immune_JJ
activation_NN
pathways_NNS
for_IN
NF-kappa_NN
B_NN
induction_NN
,_,
including_VBG
those_DT
initiated_VBN
from_IN
antigen_NN
and_CC
cytokine_NN
receptors_NNS
._.

In_IN
contrast_NN
,_,
introduction_NN
of_IN
a_DT
phosphoserine_NN
mimetic_JJ
at_IN
these_DT
sites_NNS
rectified_VBD
this_DT
functional_JJ
defect_NN
,_,
a_DT
finding_NN
consistent_JJ
with_IN
a_DT
causal_JJ
linkage_NN
between_IN
the_DT
phosphorylation_NN
status_NN
and_CC
proteolytic_JJ
stability_NN
of_IN
this_DT
cytoplasmic_JJ
inhibitor_NN
._.

Together_RB
,_,
these_DT
in_FW
vivo_FW
studies_NNS
define_VBP
a_DT
critical_JJ
signal_NN
response_NN
domain_NN
in_IN
I_NN
kappa_NN
B_NN
alpha_NN
that_WDT
coordinately_RB
controls_VBZ
the_DT
biologic_JJ
activities_NNS
of_IN
I_NN
kappa_NN
B_NN
alpha_NN
and_CC
NF-kappa_NN
B_NN
in_IN
response_NN
to_TO
viral_JJ
and_CC
immune_JJ
stimuli_NNS
._.

